RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction

NCT07166380 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Transcranial Bone Marrow Injection
RK-4
Acute Large Hemispheric Infarction
Acute Ischemic Stroke

Interventions

DRUG: RK-4 injection

Sponsor

Neurodawn Pharmaceutical Co., Ltd.

Collaborators

[object Object]